[Clinical portrait of a patient with COVID-19. The experience of a multidisciplinary clinic].

Autor:	Baimakanova GE; Loginov Moscow Clinical Scientific and Practical Center., Khatkov IE; Loginov Moscow Clinical Scientific and Practical Center., Dudina GA; Loginov Moscow Clinical Scientific and Practical Center., Chegodar AS; Loginov Moscow Clinical Scientific and Practical Center., Rumyantsev KA; Loginov Moscow Clinical Scientific and Practical Center., Sviridov FS; Loginov Moscow Clinical Scientific and Practical Center.; Bochkov Research Centre for Medical Genetics., Osipova AV; Loginov Moscow Clinical Scientific and Practical Center., Danishevich AM; Loginov Moscow Clinical Scientific and Practical Center., Noskova KK; Loginov Moscow Clinical Scientific and Practical Center., Pinashina ES; Loginov Moscow Clinical Scientific and Practical Center., Orlova NV; Loginov Moscow Clinical Scientific and Practical Center., Slezinger VM; Loginov Moscow Clinical Scientific and Practical Center., Chernova ME; Loginov Moscow Clinical Scientific and Practical Center., Tovstyko KA; Loginov Moscow Clinical Scientific and Practical Center., Bodunova NA; Loginov Moscow Clinical Scientific and Practical Center.
Jazyk:	ruština
Zdroj:	Terapevticheskii arkhiv [Ter Arkh] 2021 Nov 15; Vol. 93 (11), pp. 1283-1289. Date of Electronic Publication: 2021 Nov 15.
DOI:	10.26442/00403660.2021.11.201191
Abstrakt:	Aim: Evaluation of the clinical characteristics in patients with COVID-19. Materials and Methods: The article presents clinical and instrumental data of 1169 patients included in a single-center mixed study. Patients were tested for COVID-19 using polymerase chain reaction, computed tomography (CT), and antibody screening. Clinical history data were collected. Results: In patients with confirmed COVID-19, lung damage and a positive test for antibodies were observed in 75.5 and 45.2% of cases, respectively. The most common symptoms of COVID-19 were: fever (73.2%), weakness, (72.7%) dry cough (62.8%) and shortness of breath (55.4%). Patients with CT-visualized lung lesions were more likely to have clinical symptoms and elevated levels of antibodies. Patients with chronic diseases of the endocrine system, circulatory system, and respiratory system had a more severe course of the disease (CT-14: 91.296.3%) than patients without chronic diseases (CT-14: 85,1%). Conclusion: We have compiled a clinical profile of patients with COVID-19 and highlighted the most significant clinical characteristics corresponding to a more severe course of the disease. Our data showed that patients with chronic diseases require a personalized approach and the development of specific criteria for the diagnosis and treatment of COVID-19.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu